质母细胞瘤蛋白质的突变不会破坏表位表现和识别,保持特定的CD8 T细胞免疫反应潜力
Renata Fioravanti Tarabini1, Gustavo Fioravanti Vieira2,3, Maurício Menegatti Rigo4,5
1Laboratory of Clinical and Experimental Immunology, Infant Center, School of Health Science, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.
Scientific reports
|July 19, 2024
概括
这项研究调查了质母细胞瘤突变如何影响T细胞反应. 研究人员确定了特定的TP53突变,这些突变改变了T细胞表皮图表的呈现,为新的质母细胞瘤免疫疗法提供了潜在的标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
背景情况:
- 细胞毒性CD8T细胞对于控制多形质母细胞瘤 (GBM) 瘤生长至关重要,是免疫治疗的重点.
- 像EGFR,IDH1,PTEN和TP53这样高表达的GBM蛋白中的突变可能会影响免疫原性表位的呈现.
研究的目的:
- 调查关键GBM蛋白质突变对免疫原性表位表现的影响.
- 通过分析突变如何影响T细胞识别来确定GBM的潜在治疗点.
主要方法:
- 使用in silico工具来分析EGFR,IDH1,PTEN和TP53中的突变.
- 从免疫表皮层数据库 (IEDB) 获取了I类MHC绑定数据.
- 构建了-MHC I类 (pMHC-I) 模型,进行了聚类分析,并进行了分子动力学模拟.
主要成果:
- 鉴定了TP53中的特定点突变,这些突变显著改变了呈现.
- 在pMHC-I复合体中特征化的结构特征可能会影响CD8 T细胞识别.
- 选择的基因,其中突变不会破坏表位表现,保持T细胞免疫性.
结论:
- 特定的TP53突变可以调节GBM中的表位表现.
- 对pMHC-I复合体的结构分析为T细胞识别机制提供了洞察力.
- 鉴定出具有开发新型GBM基或mRNA疫苗潜力的.
相关概念视频
Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
T Cell Activation and Clonal Selection
696
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
696
Cytotoxic T Cells-mediated Immune Response
885
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
885


